Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Weichselbaum

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
Cancer Research|January 16, 2021
(Oligo)metastasis as a Spectrum of DiseaseStanley I Gutiontov, Sean P Pitroda, Phuoc T Tran, et al.
The Breast Journal|May 12, 2001
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast CancerMisa M. Lee, Ruth Heimann, Claire Powers, et al.
Cell & Bioscience|April 5, 2022
p52 signaling promotes cellular senescenceGiovanna M Bernal, Longtao Wu, David J Voce, et al.
Cancer Immunology Research|January 13, 2017
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor EradicationAinhoa Arina, Theodore Karrison, Eva Galka, et al.
Cancer|February 12, 2009
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive coresStanley L Liauw, Janine Fricano, David Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic DiseaseConnor Lynch, Muzamil Arshad, Rohan R Katipally, et al.
ACS Nano|January 29, 2024
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-ImmunotherapyJing Liu, Xiaomin Jiang, Youyou Li, et al.
Journal of the American Chemical Society|July 9, 2026
Retraction of "Nanoscale Donor-Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity"Jing Liu, Zhihao Zhao, Chenghua Deng, et al.
Cancer Research|September 18, 2004
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastomaBakhtiar Yamini, Xiaohong Yu, G Yancey Gillespie, et al.
The Journal of Experimental Medicine|June 5, 2025
YTHDFs as radiotherapy checkpoints in tumor immunityChuangyu Wen, Emile Z Naccasha, Chuan He, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
Cancer Research|January 16, 2021
(Oligo)metastasis as a Spectrum of DiseaseStanley I Gutiontov, Sean P Pitroda, Phuoc T Tran, et al.
The Breast Journal|May 12, 2001
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast CancerMisa M. Lee, Ruth Heimann, Claire Powers, et al.
Cell & Bioscience|April 5, 2022
p52 signaling promotes cellular senescenceGiovanna M Bernal, Longtao Wu, David J Voce, et al.
Cancer Immunology Research|January 13, 2017
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor EradicationAinhoa Arina, Theodore Karrison, Eva Galka, et al.
Cancer|February 12, 2009
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive coresStanley L Liauw, Janine Fricano, David Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic DiseaseConnor Lynch, Muzamil Arshad, Rohan R Katipally, et al.
ACS Nano|January 29, 2024
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-ImmunotherapyJing Liu, Xiaomin Jiang, Youyou Li, et al.
Journal of the American Chemical Society|July 9, 2026
Retraction of "Nanoscale Donor-Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity"Jing Liu, Zhihao Zhao, Chenghua Deng, et al.
Cancer Research|September 18, 2004
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastomaBakhtiar Yamini, Xiaohong Yu, G Yancey Gillespie, et al.
The Journal of Experimental Medicine|June 5, 2025
YTHDFs as radiotherapy checkpoints in tumor immunityChuangyu Wen, Emile Z Naccasha, Chuan He, et al.
Pageof 37